Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion type Assertion NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_head.
- NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion description "[Aberrant methylation of TFPI-2 was also detected in 73% (102/140) of pancreatic cancer xenografts and primary pancreatic adenocarcinomas, was more likely in older patients with pancreatic cancer, and significantly correlated with progression of IPMNs (P=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_provenance.
- NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion evidence source_evidence_literature NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_provenance.
- NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion SIO_000772 15592528 NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_provenance.
- NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion wasDerivedFrom befree-2016 NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_provenance.
- NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_assertion wasGeneratedBy ECO_0000203 NP472417.RAiZ8iEGhnn379qi2_PuMVVfKdA7XeJP6tpI_gC-SVsvM130_provenance.